Target intelligence / Profile preview

Phosducin-like protein 3 (PhLP3)

Target
PhLP3
Molecular classification
Other, Molecular chaperone/co-chaperone, Cytosolic protein, Thioredoxin domain-containing protein
01

Overview

Phosducin-like protein 3 (PhLP3) is a member of the phosducin-like protein family, which are small cytosolic proteins that function primarily as molecular chaperones or co-chaperones. Unlike PhLP1, PhLP3 does not play a major role in G protein signaling but instead assists the cytosolic chaperonin complex (CCT) in the folding of β-tubulin and possibly actin, thus regulating cytoskeletal dynamics[1][2][4]. PhLP3 contains a conserved thioredoxin domain and exhibits redox activity, although it does not have a canonical CXXC motif[2]. In yeast and protozoan systems, PhLP3 is essential for proper β-tubulin folding, with genetic deletion protecting cells from free β-tubulin toxicity and knockdown causing defects in microtubule architecture[1][2]. While PhLP3 is highly conserved across eukaryotes, there is limited evidence that it is a direct therapeutic target or that it plays a well-defined role in human disease[1][2][4].

Other names
Phosducin-like 3PhLP-3PLP3
02

Biological functions

Protein foldingCytoskeletal regulationRegulation of microtubules (β-tubulin folding)Regulation of actin functionCo-chaperone activity with CCT (chaperonin-containing TCP-1)
03

Disease associations

Other (no direct link to specific human diseases clearly established as of current literature)

Beyond the preview

Go deeper on Phosducin-like protein 3 (PhLP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosducin-like protein 3 (PhLP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call